Literature DB >> 10706447

Dysregulation of the protein tyrosine kinase LCK in lymphoproliferative disorders and in other neoplasias.

M B Majolini1, M Boncristiano, C T Baldari.   

Abstract

Initially identified as a T-cell specific member of the Src family of protein tyrosine kinases, Lck has become the object of intensive investigations which have revealed a key role for this kinase in the central processes controlling T-cell development, activation, proliferation and survival. Experimental evidence of the oncogenic potential of Lck, together with the identification of defects in the regulation of Lck expression or activity in T-cell leukemias, suggests that dysregulation of Lck might play a role in neoplastic transformation. Here we review the data documenting a potential role for this kinase in the initiation and maintenance of the transformed state in human cancers.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10706447     DOI: 10.3109/10428199909145727

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  7 in total

1.  Enforced SOCS1 and SOCS3 expression attenuates Lck-mediated cellular transformation.

Authors:  John C Cooper; Mingjian Shi; Fu-Yu Chueh; Srividya Venkitachalam; Chao-Lan Yu
Journal:  Int J Oncol       Date:  2010-05       Impact factor: 5.650

2.  Transcriptome profiling in oral cavity and esophagus tissues from (S)-N'-nitrosonornicotine-treated rats reveals candidate genes involved in human oral cavity and esophageal carcinogenesis.

Authors:  Ali Khammanivong; Arunkumar Anandharaj; Xuemin Qian; Jung Min Song; Pramod Upadhyaya; Silvia Balbo; Dipankar Bandyopadhyay; Erin B Dickerson; Stephen S Hecht; Fekadu Kassie
Journal:  Mol Carcinog       Date:  2016-01-19       Impact factor: 4.784

3.  Identification of protein tyrosine kinases with oncogenic potential using a retroviral insertion mutagenesis screen.

Authors:  Els Lierman; Helen Van Miegroet; Els Beullens; Jan Cools
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

4.  Suppressor of cytokine signaling 1 interacts with oncogenic lymphocyte-specific protein tyrosine kinase.

Authors:  Srividya Venkitachalam; Fu-Yu Chueh; King-Fu Leong; Samantha Pabich; Chao-Lan Yu
Journal:  Oncol Rep       Date:  2011-01-13       Impact factor: 3.906

5.  Nuclear localization of lymphocyte-specific protein tyrosine kinase (Lck) and its role in regulating LIM domain only 2 (Lmo2) gene.

Authors:  Srividya Venkitachalam; Fu-Yu Chueh; Chao-Lan Yu
Journal:  Biochem Biophys Res Commun       Date:  2011-12-27       Impact factor: 3.575

6.  Nuclear lymphocyte-specific protein tyrosine kinase and its interaction with CR6-interacting factor 1 promote the survival of human leukemic T cells.

Authors:  Shahrooz Vahedi; Fu-Yu Chueh; Sujoy Dutta; Bala Chandran; Chao-Lan Yu
Journal:  Oncol Rep       Date:  2015-05-19       Impact factor: 3.906

7.  Lymphocyte-specific protein tyrosine kinase (Lck) interacts with CR6-interacting factor 1 (CRIF1) in mitochondria to repress oxidative phosphorylation.

Authors:  Shahrooz Vahedi; Fu-Yu Chueh; Bala Chandran; Chao-Lan Yu
Journal:  BMC Cancer       Date:  2015-07-26       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.